# OnCo record paper-lutetium-177-vipivotide-tetrax-prostate-oncol-ther-2025 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-lutetium-177-vipivotide-tetrax-prostate-oncol-ther-2025/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-lutetium-177-vipivotide-tetrax-prostate-oncol-ther-2025" ;
  schema:name "Sequencing of Radium-223 and Lutetium-177 Vipivotide Tetraxetan: Maximizing the Benefit of Systemic Targeted Radiation Therapy in Metastatic Castration-Resistant Prostate Cancer"@en ;
  schema:description "Review on Lutetium-177 vipivotide tetraxetan in Prostate cancer, in Oncology and therapy (2025), one of the most cited Europe PMC records with Lutetium-177 vipivotide tetraxetan in its title."@en ;
  schema:url <https://onco.cc/key-papers/paper-lutetium-177-vipivotide-tetrax-prostate-oncol-ther-2025/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1007/s40487-025-00377-9>, <https://pubmed.ncbi.nlm.nih.gov/41060609/>, <https://europepmc.org/article/MED/41060609> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1007/s40487-025-00377-9> ;
  schema:datePublished "2025"^^xsd:gYear ;
  schema:author "Mehr S, Hauke R" .